Ibrutinib reimbursement rate

Ibrutinib (Ibrutinib) is an oral drug widely used to treat a variety of B cell malignancies, including chronic lymphocytic leukemia (CLL), small Type lymphocytic lymphoma (SLL), lymphoid follicular lymphoma (FL) and Langerhans cell histiocytic lymphoma (MCL), etc. Ibrutinib is currently on the market in China and is included in medical insurance. The domestic price ranges from 10,000 to 20,000. Due to different medical insurance policies in different places, the price is also different. For specific reimbursement information, please consult the local hospital pharmacy or medical insurance bureau. The cheaper types of ibrutinib abroad are generic drugs, mainly Indian generic drugs, Bangladeshi generic drugs and Laos generic drugs, with prices ranging from a few hundred to several thousand yuan. And the ingredients of generic ibrutinib drugs are basically the same as those of domestic ibrutinib drugs.